Given the current suggested benefits, further investigations on severe cancer stages should be conducted
Until more rigorous research and clinical studies have been performed, BPC-157 should not be taken therapeutically
LA-A: Conceptualization, Funding acquisition, Supervision, Validation, Writing review & editing
This study found that taking these three ingredients for 6 months was associated with a statistically significant improvement in sperm count and motility
#MultipleSclerosis #Biopharma #QNTM To view or add a comment, sign in Quantum BioPharma (NASDAQ: QNTM) is moving its multiple sclerosis therapy candidate, LUCID-MS, closer to patient trials after Phase 1 studies in healthy volunteers confirmed a favorable safety profile and general tolerability
Immediate Results Lip fillers have immediate results, and the lips look more voluminous and well-defined immediately after the procedure